2,2-Diphenyl-N-(2,2,2-trichloro-1-{[(4-fluoro-3-nitrophenyl)carbamothioyl]amino}ethyl)acetamide
| Title | Journal |
|---|---|
| A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. | The Biochemical journal 20130415 |
| CGK733 enhances multinucleated cell formation and cytotoxicity induced by taxol in Chk1-deficient HBV-positive hepatocellular carcinoma cells. | Biochemical and biophysical research communications 20120525 |
| Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. | Nature biotechnology 20111101 |
| CGK733 does not inhibit ATM or ATR kinase activity in H460 human lung cancer cells. | DNA repair 20111010 |
| ATM is the predominant kinase involved in the phosphorylation of histone H2AX after heating. | Journal of radiation research 20100101 |
| Scientific misconduct. Science retracts discredited paper; bitter patent dispute continues. | Science (New York, N.Y.) 20090424 |
| The ATM and ATR inhibitors CGK733 and caffeine suppress cyclin D1 levels and inhibit cell proliferation. | Radiation oncology (London, England) 20090101 |
| Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080315 |
| Small molecule-based reversible reprogramming of cellular lifespan. | Nature chemical biology 20060701 |